仙琚制药：公司将聚焦创新求突破

Core Viewpoint - The company emphasizes its commitment to innovation and breakthroughs in both raw materials and formulation development, focusing on high-tech areas and clinical needs [1] Group 1: Raw Material Development - The company aims to upgrade processes and achieve breakthroughs in high-tech fields such as sterility and crystal size [1] Group 2: Formulation Innovation - The company plans to initiate projects for modified new drugs and explore innovative targets based on clinical needs and disease mechanisms [1] Group 3: Innovation Process - The company views innovation as a continuous process of experimentation and iteration [1]